Global /Japan /Healthcare /Medical Devices /4570
chevron_leftBack
Immuno-Biological Laboratories Co., Ltd. logo

Immuno-Biological Laboratories Co., Ltd.

4570
TSE: 4570 Delayed
1,334JPY -3.8%
8.32 USD
As of 13 June 2026, Immuno-Biological Laboratories Co., Ltd. has a market cap of $80.7M USD, ranking #27069 globally and #2421 in Japan. It ranks #2428 in the Healthcare sector, and #495 in the Medical Devices industry.
Global Rank
27069
Country Rank
2421
Sector Rank
2428
Industry Rank
495
Key Stats
Market Cap
$80.7MUSD
12.92B JPY
Enterprise Value
$76.13MUSD
12.21B JPY
Revenue (TTM)
$6.44MUSD
1.03B JPY
EBITDA (TTM)
$2.08MUSD
332.75M JPY
Net Income (TTM)
$2.27MUSD
364.0M JPY
EBITDA Margin
32%
Profit Margin
35%
PE Ratio
35.5
PS Ratio
12.5
PB Ratio
7.3
EV/EBITDA
36.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Tsutomu Seito open_in_new
Employees
58
Founded
1982
Website
ibl-japan.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.8% -7.7% -1.3% -17% 190% 199%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4570
株式会社免疫生物研究所
ISIN: JP3921300004
Shares Out.:
9.313M1 Shares Float: 7.435M2
TV:
SA:
YF:
GF:
BA:
MS:
1,334 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.

Similar Companies

Industry: Medical Devices (Japan)
Name
Market Cap diff.
PE
7741
$61.41B
9.83T JPY
76K%
40.0
$22.07B
3.53T JPY
27K%
13.0
4543
$18.94B
3.03T JPY
23K%
23.7
7733
$10.76B
1.72T JPY
13K%
20.7
7701
$6.58B
1.05T JPY
8K%
18.6
$5.47B
875.04B JPY
7K%
50.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
215K%
25.8
$160.73B
199K%
56.7
$159.07B
197K%
25.6
DHR
$126.55B
157K%
34.7
SYK
$120.69B
149K%
38.3
MDT
$101.9B
126K%
22.2
chevron_leftBack